Richard van Hillegersberg

Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer

Pieter C. van der Sluis, Sylvia van der Horst, Anne M. May et al. · Annals of Surgery · 2018 · 619 citations

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 334 citations

Terminal Ileitis, Gastroenterology, Multicentre Trial +4

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

Bo Jan Noordman, Manon C.W. Spaander, Roelf Valkema et al. · The Lancet Oncology · 2018 · 320 citations

Residual Disease, Surgical Oncology, Esophageal Cancer +11

Preoperative MRI and surgical management in patients with nonpalpable breast cancer: The MONET – Randomised controlled trial

Nicky H. G. M. Peters, Stijn van Esser, Maurice A. A. J. van den Bosch et al. · European Journal of Cancer · 2010 · 311 citations

Surgical Oncology, Breast Oncology, Medical Imaging +12

Textbook outcome as a composite measure in oesophagogastric cancer surgery

Linde A. D. Busweiler, Maartje G. Schouwenburg, Mark I. van Berge Henegouwen et al. · British journal of surgery · 2017 · 281 citations